Skip to main content
OpenTrials
Completed

NCT Number: NCT00154024

Comparison of Vascular Effects After Therapy With Irbesartan and Atorvastatin.

Vascular responses to angiotensin II and histamine are compared before and after 30 days of systemic treatment with either irbesartan 150 mg or atorvastatin 20 mg.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy Subjects

Age range

18 year–45 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Institute of Clinical Pharmacology, Medical Faculty, University of Technology

Dresden, 01307, Germany

About this study

Vascular responses to angiotensin II and histamine are compared before and after 30 days of systemic treatment with either irbesartan 150 mg or atorvastatin 20 mg.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy subjects
  • no relevant disease
  • amendment: hypercholesterolaemic subjects

Exclusion criteria

  • any relevant disease

Treatment and study plan

atorvastatin

Drug

Irbesartan

Drug

Primary outcomes

  1. vascular responses after treatment.

Sponsors and collaborators

Lead sponsor

Technische Universität Dresden

Other

Registry information

Official study title

Characterization of Local Vascular Effects of Angiotensin II and Histamine After Treatment With Irbesartan and Atorvastatin.

Important dates

Study start
2003
Study completion
2006
First posted
Sep 12, 2005
Registry last updated
Sep 28, 2006

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.